Please check your internet connection and try again.
# Daidzein + Genistein + Palmitoylethanolamide (DGP)
## Overview
Daidzein, genistein (isoflavones found in soy), and palmitoylethanolamide (PEA) are often combined in dietary supplements intended for various health benefits. Their proposed mechanisms involve anti-inflammatory, antioxidant, and potential hormonal modulation effects. Evidence supporting the efficacy and safety of this specific combination is limited, and it is primarily marketed as a supplement rather than a prescription medication.
## Primary Indications
This combination is generally marketed for:
* Pain management (e.g., neuropathic pain, inflammatory pain)
* Inflammation reduction
* Nerve support
## Adult Dosing
Dosing varies widely among commercially available products. A common range found in supplements is:
* **Daidzein:** 50-100 mg daily
* **Genistein:** 50-100 mg daily
* **Palmitoylethanolamide (PEA):** 300-1200 mg daily, often divided into multiple doses.
Specific product formulations may dictate the precise milligram amounts and frequency. It is crucial to follow the manufacturer's recommended dosage on the product label or as advised by a healthcare professional.
## Pediatric Dosing
Established pediatric dosing for this specific combination is **not available**. Safety and efficacy have not been studied in children.
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established due to the lack of formal clinical trials and its status as a supplement. Caution is advised in patients with pre-existing conditions.
## Contraindications
* Hypersensitivity to any component of the formulation.
* Patients with hormone-sensitive cancers (e.g., breast, ovarian, uterine, prostate) should exercise caution due to the phytoestrogenic nature of daidzein and genistein, although clinical significance is debated.
## Adverse Effects
Adverse effects are generally mild and may include:
* Gastrointestinal upset (nausea, diarrhea, bloating)
* Allergic reactions (rare)
## Key Drug Interactions
* **Hormonal Therapies:** Potential for interaction with hormone replacement therapy or other estrogen-modulating drugs due to the phytoestrogenic effects of soy isoflavones.
* **Anticoagulants/Antiplatelets:** Soy isoflavones may have mild antiplatelet effects; caution with concomitant use.
* **Thyroid Medications:** Soy isoflavones may interfere with thyroid hormone absorption or metabolism. Separate administration by at least 4 hours.
## Monitoring
* Monitor for adverse effects.
* Assess for treatment efficacy based on patient-reported symptoms.
* Given the lack of robust data, routine laboratory monitoring is generally not indicated unless specific concerns arise related to interactions or underlying conditions.
## Clinical Pearls
* This combination is available as a dietary supplement and does not require a prescription.
* Individual responses can vary significantly.
* It is essential to counsel patients about the supplement nature of this product and the limited clinical evidence for this specific combination.
* Advise patients to inform their healthcare providers about all supplements they are taking.
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for comprehensive drug information resources or professional medical advice. Always consult the most current prescribing information and local protocols before making any treatment decisions.
